AirSculpt Technologies, Inc. (AIRS) vs Fortress Biotech, Inc. (FBIOP)
A side-by-side comparison of AirSculpt Technologies, Inc. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIRS
AirSculpt Technologies, Inc.
$1.91HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FBIOP
Fortress Biotech, Inc.
$18.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AIRS vs FBIOP
growth of $100 · dividends reinvested · last 5yAIRS -87.4% (-34.0%/yr)FBIOP -1.1% (-0.2%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
AIRS FBIOP
AIRS vs FBIOP: by the numbers
- •FBIOP is the larger company ($142M vs $135M market cap).
- •FBIOP is profitable (163.32% net margin) while AIRS runs a net loss (-7.79%).
- •AIRS grew revenue faster over the past five years (8.17% vs 5.39% CAGR).
Metrics side by side
Valuation
| Metric | AIRS | FBIOP |
|---|---|---|
| P/E ratio | N/A | 6.75 |
| Forward P/E | N/A | 7.10 |
| P/S ratio | 0.89 | 2.08 |
| P/B ratio | 1.29 | 0.87 |
| EV / EBITDA | 438.56 | N/A |
| FCF yield | 0.56% | 88.32% |
Profitability
| Metric | AIRS | FBIOP |
|---|---|---|
| Gross margin | 57.63% | 62.53% |
| Operating margin | -7.85% | -111.00% |
| Net margin | -7.79% | 163.32% |
| ROE | -11.20% | 68.12% |
| ROIC | -7.01% | -10.85% |
Growth (annualized)
| Metric | AIRS | FBIOP |
|---|---|---|
| Revenue CAGR (5Y) | 8.17% | 5.39% |
| FCF CAGR (5Y) | -52.36% | N/A |
| Total return CAGR (5Y) | N/A | 0.05% |
Frequently asked
- Which has grown faster, AIRS or FBIOP?
- Over the past five years, AIRS grew revenue faster — AIRS at a 8.17% CAGR versus FBIOP at 5.39%.
- Is AIRS or FBIOP more profitable?
- FBIOP runs the higher net margin — AIRS at -7.79% versus FBIOP at 163.32%.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioAirSculpt Technologies ROEFortress Biotech ROEAirSculpt Technologies operating marginFortress Biotech operating marginAirSculpt Technologies revenue growthFortress Biotech revenue growthAirSculpt Technologies free cash flowFortress Biotech free cash flow
AirSculpt Technologies & Fortress Biotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.